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This study evaluated the incidence and risk factors of bloodstream infection (BSI) among 
patients with a double-lumen central venous catheter (CVC) for hemodialysis (HD) and 
identified the microorganisms isolated from the bloodstream. A follow-up included all patients 
(n=156) who underwent hemodialysis by double-lumen CVC at the Federal University 
of São Paulo – UNIFESP, Brazil, over a one-year period. From the group of patients, 94 
presented BSI, of whom 39 had positive cultures at the central venous catheter insertion 
location. Of the 128 microorganisms isolated from the bloodstream, 53 were S. aureus, 30 
were methicillin-sensitive and 23 were methicillin-resistant. Complications related to BSI 
included 35 cases of septicemia and 27 cases of endocarditis, of which 15 cases progressed 
to death. The incidence of BSI among these patients was shown to be very high, and this 
BSI progressed rapidly to the condition of severe infection with a high mortality rate.
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Incidência de infecção da corrente sanguínea nos pacientes submetidos 
à hemodiálise por cateter venoso central
O objetivo deste estudo foi avaliar a incidência e os fatores de risco de infecção da 
corrente sanguínea (ICS) em pacientes com cateter venoso central (CVC) duplo lúmen, 
para hemodiálise (HD) e identificar os micro-organismos isolados na corrente sanguínea. 
Como método, usou-se o follow up, realizado no período de um ano, incluindo todos os 156 
pacientes que estavam em tratamento de HD por CVC duplo lúmen, na Universidade Federal 
de São Paulo - UNIFESP. Os resultados mostraram que dos 156 pacientes estudados, 94 
apresentaram ICS, desses, 39 tiveram culturas positivas no local de inserção do cateter. 
Dos 128 micro-organismos isolados da corrente sanguínea, 53 eram S.aureus, dos quais 
30 eram sensíveis à metilcilina e 23 resistentes. Entre as complicações relacionadas à 
ICS, houve 35 casos de septicemia e 27 casos de endocardite, dos quais 15 progrediram 
a óbito. A incidência de ICS neste grupo de pacientes mostrou-se bastante elevada bem 
como sua progressão para quadros infecciosos de grande magnitude e óbito.
Descritores: Cateterismo; Diálise Renal; Staphylococcus aureus.
Incidencia de infección de la corriente sanguínea em los pacientes 
sometidos a hemodiálisis por catéter venoso central
El objetivo de este estudio fue evaluar la incidencia y los factores de riesgo de infección 
de la corriente sanguínea (ICS) en pacientes con catéter venoso central (CVC) doble 
lumen, para hemodiálisis (HD) e identificar los microorganismos aislados en la corriente 
sanguínea. Como método, se uso el acompañamiento, realizado en el período de un año, 
incluyendo todos los 156 pacientes que estaban en tratamiento de HD por CVC doble 
lumen, en la Universidad Federal de Sao Paulo - UNIFESP. Los resultados mostraron que 
de los 156 pacientes estudiados, 94 presentaron ICS, de estos, 39 tuvieron culturas 
positivas en el local de inserción del catéter. De los 128 microorganismos aislados de la 
corriente sanguínea, 53 eran S.aureus, de los cuales 30 eran sensibles a la metilcilina y 23 
resistentes. Entre las complicaciones relacionadas a la ICS, hubo 35 casos de septicemia 
y 27 casos de endocarditis, de los cuales 15 resultaron en muerte. La incidencia de ICS 
en este grupo de pacientes se mostró bastante elevada así como su progresión para 
cuadros infecciosos de gran magnitud y de muerte.
Descriptores: Cateterismo; Diálisis Renal; Staphylococcus aureus.
Introduction
Central venous catheters (CVC) are a reliable option 
for clinical situations requiring immediate vascular 
access for hemodialysis, as in the case of patients with 
uremia(1).
A variety of mechanisms have been proposed to 
determine the sources of microorganisms that colonize 
CVCs and lead to infections. Studies have focused mainly 
on: the patient’s skin around the exit site and to a 
lesser extent contamination of the catheter connection; 
colonization of the catheter by hematogenic dissemination 
coming from another site; and/or contamination of the 
infusion fluid. Other possibilities are the occurrence of 
catheter contamination at the time of insertion as a 
result of a lack of aseptic technique or through iatrogenic 
contamination during subsequent manipulations of 
the catheter. This last category of possible catheter 
contaminations may originate from the hands and/or 
respiratory tracts of health care providers(2). Moreover, 
patients on dialysis are known to suffer from impaired 
immune defense mechanisms, attributable to the 
larger proportions of elderly polymorbid patients with 
conditions such as diabetes mellitus and malignancies, 
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in addition to malnutrition, particularly related to uremia 
and HD treatment(3).
Among the microorganisms responsible for 
Bloodstream Infection (BSI) in hemodialysis patients, 
S. aureus is the most important. Data in the literature 
have shown high morbidity and mortality rates among 
patients who develop BSI related to the use of CVCs for 
hemodialysis(4-5). Consequently, there is a rise in both 
hospital costs and microbial resistance(1,6). Therefore, 
the prevention of such BSI needs to be considered a 
priority matter in programs for infection control and 
hospital quality control assessment.
There were no data about the incidence of hospital 
infections in the nephrology service at the UNIFESP- 
Brazil. Therefore, the present study was designed to 
evaluate the prevalence of risk factors for BSI among 
patients with double-lumen CVC for hemodialysis, 
and to identify the microorganisms isolated from the 
bloodstream of patients. It was assumed that results of 
this study would bring important clinical contributions 
for preventing this major infectious complication in 
patients on hemodialysis by double-lumen CVC in the 
institution.
Objective
- To evaluate the incidence and the risk factors of BSI 
among patients with a double-lumen central venous 
catheter for hemodialysis;
- To identify the microorganisms isolated from the blood 
stream in these patients.
Methods
The study was approved by the institutional review 
board, and informed consent was obtained from all 
participants.
Design, location, and period of the study
A follow up was conducted at the Federal University 
of São Paulo, a tertiary referral center in São Paulo, 
Brazil, with a dialysis unit that serves 40 to 50 patients 
weekly.
Patients
The study included 156 new end-stage renal disease 
(ESRD) patients without permanent venous access and 
urgently in need of hemodialysis. Patients were excluded 
if they had acute renal failure or presented septicemia or 
another source of infection.
All venous catheters (Mahurkar® dual lumen 
catheters, Quinton Instrument Co., Bothell, WA) were 
inserted aseptically by nephrology staff physicians, 
either in the internal jugular or subclavian veins using the 
Seldinger technique. All catheters were sutured in place 
without a subcutaneous tunnel or adhesive transparent 
dressing. After initial insertion of the catheters, only 
nephrology nurses trained in hemodialysis changed the 
dressings or manipulated the catheters, using rigorous 
aseptic techniques. The catheters were locked with 
2500 to 3000 IU of heparin sodium both at the time of 
insertion and after each dialysis.
The patients selected for the study were assigned 
to receive skin disinfection at the catheter insertion site 
with 70% P/V alcohol solution. The exit site, catheter 
hub, and line connections were covered with sterile, 
occlusive gauze dressing.
At the time of inclusion in the study, demographic 
and clinical data were recorded.
Follow- up
The catheters’ dressings were removed before each 
dialysis. A nurse assessed the exit site for inflammation 
or the presence of pus at the dressing change and when 
the catheter was removed. Participants were followed 
up with until the catheter was removed, which occurred 
for the following reasons: catheter malfunction, 
the presence of local erythema and/or a purulent 
discharge, or BSI without another identifiable source 
of infection, accordingly to Kidney Disease Outcomes 
Quality Initiative (KDOQI) recommendations. If local 
erythema alone was present, the catheter was left in 
situ, provided there was no evidence of BSI. No patient 
was lost to follow-up, and no catheter was exchanged 
over a guidewire. No patient used more than one 
catheter during the study period. Catheters were only 
used for hemodialysis.
Immediately before catheter removal, the skin 
around the site was cultured with a saline-moistened 
cotton swab and then cleaned with povidone iodine. Exit 
site cultures were also obtained when there was a clinical 
suspicion of skin infection. If a patient presented a fever 
(37.8 ºC), with or without other signs of infection, blood 
cultures were collected from peripheral veins, using 
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standard aseptic techniques. All catheters were removed 
in the dialysis unit of São Paulo Hospital.
Definition of terms
Skin Infections: Presence of one or more of the 
following signs or symptoms with no other recognized 
cause: pain or tenderness, localized swelling, redness, 
or heat and the growth of microorganisms in skin 
cultures(7-8)
Colonization of the Catheter Tip: Semiquantitative 
culturing of catheter tips containing 15 or more colony-
forming units (cfu) per dish(7-8).
Bloodstream infection: Acknowledged according to 
the following criteria: 1) presence of one or more positive 
blood cultures (collected from peripheral veins) while 
the catheter was in place; 2) presence of fever greater 
than 37.8°C accompanied by chills, or hypotension; 
3) evaluation of data from clinical examination, chest 
x-ray, and laboratory and microbiological investigation 
that do not suggest another source for the bacteremia; 
and 4) presence or absence of positive culture from the 
catheter tip(7-8).
Microbiology
Pericatheter skin samples were obtained using sterile, 
pre-moistened calcium alginate swabs (Cefar-Farmaco 
Diagnostic, São Paulo, Brazil) and were transported to 
the microbiology laboratory of São Paulo Hospital, where 
they were immediately streaked onto plates containing 
tryptic soy agar with 5% sheep blood and mannitol-salt 
agar (DIFCO Laboratories, Detroit, MI). All cultures were 
incubated at 35ºC for 48 hours and examined daily for 
evidence of growth. Gram-positive cocci that produced 
catalase and coagulase were identified as S. aureus. 
Methilcillin- resistant S.aureus strains were defined 
as a zone of inhibition less than 11 mm (disk content 
of methilcillin was 1 µg). Blood samples (20ml) were 
collected in Bactec bottles, and cultures were processed 
by an automated method of isolation for microorganisms 
(Bactec 9240, Becton Dickinson).
After the catheter was removed, approximately 50 
mm of the catheter tip was rolled across Rodac plates 
containing tryptic soy agar with 5% sheep blood (AS, 
Oxoid, Basingstoke, Hampshire, United Kingdom), and 
mannitol-salt agar (ASM, Oxoid), prepared previously 
in the laboratory, according to the semi-quantitative 
method. Catheters yielding more than 15 colony-forming 
units were considered significantly colonized(7).
Statistical analysis
Patients were classified into 2 groups: with and 
without BSI. Descriptive analysis of each of these 2 
groups was performed considering demographic, clinical 
and laboratory variables and parameters relating to 
dialysis. After this, univariate analysis was performed. 
Associations between BSI and categorical variables 
were tested by using chi-square and Fisher’s exact 
tests. Associations between continuous variables and 
BSI were tested by using Student’s t- test or the Mann-
Whitney test, as appropriate. Multivariate analysis was 
also performed by means of stepwise logistic regression 
to investigate factors associated with BSI. Independent 
variables tested were those that presented P less than 
0.01 in univariate analysis. Relative risk (RR) and 95% 
confidence intervals (CIs) were calculated. The tests 
used were bimodal and the significance level was set 
at p less than 0.05. Microbiological analyses were 
performed in accordance with the norms of the National 
Committee for Clinical Laboratory Standards (NCCLS). 
The statistical program used was SPSS (version 14.0).
Results
Of the 156 patients that entered the study; 94 
developed BSI. All patients were followed until catheter 
removal. Table 1 shows the baseline characteristics: 
sociodemographic, clinical data and treatment of the 
patients who underwent hemodialysis via CVC in the 
study.
In relation to base diseases, patients with 
hypertension and diabetes mellitus presented an 
increased risk of developing BSI, 22% (RR: 1,22; 95% 
confidence interval: 0.86-3.14) and 37% (RR: 1.37; 
95% confidence interval: 1.16-5.26) respectively.
As for the CVC insertion site, there were more 
catheters implanted in a subclavian vein (n=92), 
compared to the jugular vein (n= 64), where patients 
who had double-lumen CVC implanted in the jugular 
vein were 56% more likely (RR: 1.56; 95% confidence 
interval: 1.50 – 5.65) to develop BSI than those who 
had the catheter implanted in a subclavian vein.
The duration of catheterization and length of 
hospitalization were significantly higher (p=0.04 and p 
< 0.001) among patients who had BSI (Table 1).
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Table 1 - Sociodemographic Characteristics, Clinical Data and Treatment for the Patients who Underwent Hemodialysis 
by Double-lumen CVC and Evolved with and without BSI
Characteristics
Positive for BSI (n = 94) Negative for BSI (n = 62) Relative risk (95%) 
confidence interval)n (%) n (%)
Sex
Male 49 (59.8%) 33 (40.2%) 0.98 (0.50- 1.81)
Female 45 (60.8%) 29 (39.2%) 1.01 (0.55- 1.98)
Average age (with range) 51 (14 – 94) 53 (17 – 78) 0.59 (0.08- 0.45)
Race
White 54 (62.4%) 31 (37.6%) 1.12 (0.70- 2.57)
Non-white 40 (57.7%) 31 (42.3%) 0.88 (0. 38- 1.41)
Underlying disease*
Hypertensive disease 57 (65.5%) 30 (34.5%) 1.22 (0.86- 3.14)
Diabetes mellitus 35 (74.5%) 12 (25.5%) 1.37 (1.16- 5.26)
Autoimmune disease 16 (55.2%) 13 (44.8%) 0.89 (0.34- 1.74)
Cardiopathy 16 (64.0%) 9 (36.0%) 1.07 (0.49- 2.93)
Neoplastic disease 4 (57.1%) 3 (42.9%) 0.94 (0.18- 4.04)
Implantation location
Jugular vein 65 (69.0%) 27 (43.5%) 1.56 (1.50- 5.65)
Subclavian vein** 29 (31.0%) 35 (56.5%) 0.64 (0.17- 0.66)
Average duration of catheterization (days) (with range)** 19 (2 – 90) 13 (2 – 23) 0.98 (0.43- 2.10)
Average length of hospitalization (days) (with range)** 29 (5 – 120) 12 (2 – 38) 1.25 (0.86 – 4.00)
Note: values are presented as number of patients (n) and percentage (%), or as average and range;* Some patients presented more than one underlying 
disease; ** p < 0.001
The complications related to the use of the double-
lumen CVC that affected the patients undergoing 
hemodialysis and developed BSI are presented in Table 
2. The patients with positive cultures from the catheter 
tip presented a relative risk of developing BSI three 
times higher compared to the patients with positive 
cultures from local skin infections (RR: 3.01; 95% 
confidence interval: 1.33 – 6.81). Patients with positive 
exit site cultures had a 1.3 times greater chance of 
developing BSI, compared to patients with negative exit 
site cultures.
Patients who presented BSI had a 50% higher risk 
of death compared to the group without BSI (Table 2).
Table 2 - Complications related to the use of the double-
lumen CVC with and without BSI
Complications
Positive for 
BSI (n = 94)
Negative for 
without BSI 
(n = 62)
Relative risk (95% 
confidence interval)
n (%) n (%)
Skin infection 39 (41.5%) 20 (32.2%) 1.29 (0.83 – 1.98)
Catheter tip 
infection**
34 (36.1%) 6 (9.8%) 3.01 (1.33 – 6.81)
Endocarditis* 27 (28.7%) --
Septicemia 35 (37.2%) --
Death** 27 (28.7%) 6 (9.8%) 1.50 (1.19 – 1.88)
Values are presented as number of patients (n) and percentage (%)
* Out of the 27 deaths, 15 had endocarditis diagnosis
** p < 0.001.
Table 3 shows more detailed results of all 
microorganisms isolated from the bloodstream collected 
from patients with BSI. In 128 microorganisms isolated 
from the bloodstream 49% were Gram-positive, of which 
56.6% were methicillin-sensitive staphylococcus aureus 
and 43.4% were methicillin-resistant S.aureus.
Table 3 - Microorganisms (n = 128) isolated from the 
blood cultures and causing BSI
Microorganisms Positive for BSI (n = 94)
Gram-positive 62 (48.4%)
MSSA 30 (56.6%)
MRSA 23 (43.4%)
Gram-negative 58 (45.3%)
Gram-negative S* 33 (56.9%)
Gram-negative MR** 25 (43.1%)
Fungi 8 (6.2%)
* sensitive
** multiresistant
n= patients number
Discussion
The incidence of end-stage renal disease (ESRD) 
has risen dramatically over the last decade. In the 
United States alone, of 336.000 patients on dialysis 
(2004), 315.000 were undergoing hemodialysis, and the 
incidence has been increasing at the rate of 6% per year. 
The mean age of HD patients is increasing over time; 
Grothe C, Belasco AGS, Bittencourt ARC, Vianna LAC, Sesso RCC, Barbosa DA.
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today 26% of the HD population in the US is made up of 
elderly patients(9).
On the other hand, even though this incidence is 
growing alarmingly, the survival of these renal patients 
as a whole is improving. According to the United States 
Renal Data System (USRDS), the mortality rates in the 
patients on peritoneal dialysis with a transplant are 
falling, whereas in patients on hemodialysis, the rate 
continues to rise , with an increase of 10% from 2003 to 
2004, when the mortality rates rose from 243 per 1000 
patients/year to 267 per 1000 patients/year(9).
Among the diverse factors identified by these authors 
as being responsible for the raised incidence of infection 
in patients undergoing hemodialysis are: associated 
uremia immunosuppression, lack of aseptic technique 
in the access and manipulation of the vascular access, 
age of the catheter, the number of HD sessions. Long-
term catheter use and a large number of hemodialysis 
sessions have been described as leading factors related 
to infection in HD patients, associated with a high-risk 
of developing sepsis or colonization of the catheter(1). 
The cumulative hazard of catheter-related bacteremia 
was significantly magnified 3 weeks after insertion(5). 
Moreover, a higher incidence of vascular access infection 
was related to longer periods of hospitalization(6,10).
In an analytical epidemiological cohort study, 
conducted in 630 patients with CVC in seven intensive care 
units of the Federal District, Brazil, the catheterization 
time was statistically significant for the presence of 
infection (p <0.001) and the time of hospitalization was 
3.5 times higher in the group of patients who had blood 
infections related to the CVC(11). These reported findings 
are in accordance with the results found in the present 
study, namely the duration of catheter use and length of 
hospitalization that were significantly higher (p < 0.001) 
among patients who developed BSI.
Bacteremia occurred most frequently in catheters 
that remained implanted for more than 10 days. The 
incidence of bacteremia has been found to be greater in 
hospitalized patients than in outpatients(12).
Many studies have confirmed the correlation between 
the microorganisms identified on the skin around the 
catheter and those isolated from the catheter tip(1,12). 
CVC become colonized either through extraluminal 
(skin-related) or intraluminal (hub or perfusate related) 
routes. In the first case, organisms migrate from the exit 
site along the catheter and then reach the bloodstream. 
In the second, the catheter hubs are contaminated 
during catheter manipulation by dialysis personnel. 
Then, the colonizing bacteria spread into the lumen 
of the catheter(2). For long-term catheters, particularly 
those cuffed and/or surgically implanted, the hub is a 
major source of colonization in catheters(1).
In the present study, the relative risk of BSI was 
three times higher (RR: 3.01; 95% confidence interval: 
1.33- 6.81; p< 0.001) in patients who had concomitantly 
present microorganisms in the tip of the catheter and in 
the bloodstream. Furthermore, patients with a positive 
skin culture around the catheter had a relative risk of 
developing BSI about 1.3 times higher (RR: 1.29; 95% 
confidence interval: 0.83-1.98; p< 0.001).
Studies found that the risk of infection increased 
significantly with insertion into the internal jugular vein 
(RR: 4.2; 95% confidence interval: 2.0–8.8) compared 
to insertion into a subclavian vein(1). However, this 
risk always has to be weighed against non-infectious 
complications (pneumothorax, bleeding, and vein 
stenosis) associated with subclavian vein insertion(9).
In this study, patients who had a central venous 
catheter implanted in the jugular vein presented a 56% 
higher (RR: 1.56; 95% confidence interval: 1.50 – 5.65) 
chance of developing BSI than did those who had the 
catheter implanted in a subclavian vein, in agreement 
with the current literature.
Bacterial infections in dialysis patients seem to 
progress rapidly, and recovery is slower than in non-
uremic patients. This fact may be related to immunological 
alterations in patients with terminal chronic renal 
insufficiency, which include: deficient humoral immunity 
due to deficiencies in amino acids, vitamins B, C, D 
and E, and zinc; increased activity of suppressor cells, 
anorexia due to retention of nitrogenated products, 
and significant anemia secondary to erythropoietin 
deficiency. Accidental losses of iron during dialysis, 
and also diminished survival of erythrocytes in uremia, 
also increase the risk of infectious processes that are a 
predictive factor for mortality(4).
Metastatic complications occur in a large proportion 
of chronic renal patients with bacteremia related to CVC; 
these complications include: endocarditis, osteomyelitis, 
septic arthritis, septic pulmonary emboli, and spinal 
epidural abscesses(13-14).
In a study including 210 patients with ESRD who 
were undergoing chronic hemodialysis, 31% developed 
complications due to S. aureus Bacteremia. Of these, 
endocarditis was present in 17.1%, abscess in 5.7%, 
sepsis in 4.8% and 3.4% other complications(11). 
Infectious complications associated with temporary HD 
catheters represent one of the most important sources 
of morbidity and mortality among these patients(15-16).
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Septicemia accounts for almost 11% of mortalities 
among HD patients(16). IE in HD patients has a poor 
prognosis, as illustrated by in-hospital and one-year 
death rates ranging from 25 to 45% and from 46 to 
75% respectively(17).
In 1999, for the first time since the National 
Nosocomial Infections Surveillance (NNIS) has been 
reporting susceptibilities, more than 50% of all S aureus 
isolates from ICUs were resistant to Oxacillin(10) and in 
2003 this number increased by 60%. S. aureus has a 
unique predilection to cause fatal infections among 
those who have CVCs(14).
In the present study, among the 128 microorganisms 
isolated from blood cultures in the patients who presented 
BSI, 62 microorganisms were Gram-positive cocci, of 
which 56.6% were MSSA and 43.4% were MRSA and 8 
microorganisms were fungi. The high fungi and bacterial 
infection rates found in these patients can be related to 
their uremic immunosuppression(4).
MRSA strains associated with the health system are 
generally not only resistant to beta-lactamic antibiotics, 
but also load diverse mutations and genes of resistance 
for, as an example, vancomycin, to which it remained 
sensitive for decades. Currently, strains not only 
resistant to vancomycin but also to teicoplamina have 
been isolated from the blood streams of hospitalized 
patients, leaving limited therapeutical options(10).
Patients hospitalized with infection for S.aureus have 
5 times higher risk of mortality(3). Mortality associated 
with bacteremia caused by S.aureus varies from 11.9 
to 46.5% per year(3). During this study, there were 27 
deaths that were caused by infectious complications 
related to central venous catheter BSI. The present 
study showed that the risk of death among patients who 
presented BSI was 50% higher than in patients without 
BSI.
This study data led to another article where the 
high lethality rate due to complications related to 
infective endocarditis (56%) is analyzed. The most 
frequent cause of death was septicemia (54%), and this 
was accompanied by cardiac insufficiency in 33% of the 
cases and by embolism in 13% of the cases(18).
This study identified a high mortality rate in São 
Paulo Hospital dialysis patients and alerted us to the 
necessity to undertake new studies looking to minimize 
this alarming trend. Now that the causes of these BSIs 
have been related to catheter use, catheter infection 
prevention measures should be revised and reinforced 
with urgency. To avoid the spread of infection, rigorous 
measures must be utilized, ranging from washing hands 
to isolating patients with resistant strains and using 
individual personal protective equipment.
Conclusion
The incidence of BSI among patients who use a 
double-lumen CVC was very high (61%). Likewise, 
progression of this BSI to conditions of severe infection 
occurred frequently. The risk factors for developing 
BSI in this study were: implantation of the catheter in 
the internal jugular vein, duration of catheter use, and 
length of hospitalization. The mortality rate was 29% for 
patients who developed BSI and 55.5% of those who 
progressed to endocarditis. Among the microorganisms 
isolated, the ones most frequently found were Gram-
positive, of which S. aureus was the most prevalent; 
56.6% was MSSA and 43.4% was MRSA.
This study is in line with the current literature, 
complementing results of studies previously published in 
this journal, reinforcing that once hospitals learn which 
infections are most prominent in CVC related infections, 
efforts can be made to improve hospital infection 
control measures, including educating staff on proper 
techniques for the insertion and maintenance of CVCs, 
and instituting more efficient and effective quality control 
measures in hospital environments. These efforts and 
measures will contribute much to shortening hospital 
stays, decreasing mortality rates among hospitalized, 
hemodialysis patients, and providing better outcomes 
for those infected with S. aureus microorganisms.
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